Predicting early post-chemotherapy adverse events in patients with hematological malignancies: a retrospective study

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Xiaoming FeiYu Tang

Abstract

The purpose of this study was to develop a mathematical model that predicts the definite adverse events following chemotherapy in patients with hematological malignancies (HMs). This is a retrospective cohort study including 1157 cases with HMs. Firstly, we screened and verified the independent risk factors associated with post-chemotherapy adverse events by both univariate and multivariate logistic regression analysis using 70 % of randomly selected cases (training set). Secondly, we proposed a mathematical model based on those selected factors. The calibration and discrimination of the model were assessed by Hosmer-Lemeshow (H-L) test and area under the receiver operating characteristic (ROC) curve, respectively. Lastly, the predicative power of this model was further tested in the remaining 30 % of cases (validation set). Our statistical analysis indicated that liver dysfunction (OR = 2.164), active infection (OR = 3.619), coagulation abnormalities (OR = 4.614), intensity of chemotherapy (OR = 10.001), acute leukemia (OR = 2.185), and obesity (OR = 1.604) were independent risk factors for post-chemotherapy adverse events in HM patients (all P < 0.05). Based on the verified risk factors, a predictive model was proposed. This ...Continue Reading

References

Aug 29, 2000·Critical Reviews in Oncology/hematology·M Extermann
Apr 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hilmar WisplinghoffMichael B Edmond
Nov 25, 2003·BMJ : British Medical Journal·Paris P TekkisJeffrey D Stamatakis
Dec 3, 2008·Blood Reviews·Leon J Worth, Monica A Slavin
Oct 6, 2009·Bone Marrow Transplantation·T E DeForC T Le
Mar 2, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter C AlbertsenGrace L Lu-Yao
May 25, 2011·Journal of the National Cancer Institute·C Martin TammemagiPhilip C Prorok
Jul 2, 2011·Journal of the National Cancer Institute·Jennifer L PatnaikDana Dabelea
Aug 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arti HurriaWilliam P Tew
Oct 14, 2011·Leukemia & Lymphoma·Brian T Hill, John Sweetenham
Nov 30, 2011·Annals of Hematology·L PaganoUNKNOWN Hema e-Chart Group, Italy
Jan 6, 2012·Mediterranean Journal of Hematology and Infectious Diseases·Anna FalangaCarmen J Tartari
Apr 3, 2012·World Journal of Gastrointestinal Oncology·Massimo MarignaniGianfranco Delle Fave
Aug 9, 2012·Journal of Hepatology·Parag MahaleHarrys A Torres
Sep 28, 2012·Current Opinion in Oncology·Anna FalangaLaura Russo
Dec 29, 2012·PloS One·Mario TumbarelloUNKNOWN He.M.A.B.I.S. (Hematological Malignancies Associated Bacterial Infections Surveillance) Italy
Apr 23, 2013·International Journal of Hepatology·Jun Murakami, Yukihiro Shimizu
May 31, 2013·American Journal of Hematology·Michael Hallek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.